- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of systemic juvenile idiopathic arthritis
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1038/s41584-023-01042-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UnDRESSing Systemic Juvenile Idiopathic Arthritis Lung Disease
- (2023) Edward M. Behrens ARTHRITIS CARE & RESEARCH
- Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic‐Exposed Children With Systemic Juvenile Idiopathic Arthritis
- (2023) Holly Wobma et al. ARTHRITIS CARE & RESEARCH
- HLA–DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis
- (2023) Alison M. Lerman et al. ARTHRITIS CARE & RESEARCH
- Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
- (2023) Deepak Chellapandian et al. Frontiers in Pediatrics
- Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
- (2023) Grant S. Schulert et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants
- (2023) Remco G. A. Erkens et al. Arthritis & Rheumatology
- Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
- (2022) Yoshiya Tanaka et al. Nature Reviews Rheumatology
- Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers
- (2022) Guangbo Chen et al. Arthritis & Rheumatology
- Juvenile idiopathic arthritis
- (2022) Alberto Martini et al. Nature Reviews Disease Primers
- Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial
- (2022) Joachim Gerss et al. ANNALS OF THE RHEUMATIC DISEASES
- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
- (2022) Karen B. Onel et al. Arthritis & Rheumatology
- The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
- (2022) Bryce A. Binstadt et al. Arthritis & Rheumatology
- Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
- (2022) William G. Ambler et al. ANNALS OF MEDICINE
- OP0194 COMBINATION ANAKINRA AND TOCILIZUMAB TO TREAT REFRACTORY MACROPHAGE ACTIVATION SYNDROME TRIGGERED BY ADULT-ONSET STILL’S DISEASE.
- (2022) E. Alveyn et al. ANNALS OF THE RHEUMATIC DISEASES
- What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?
- (2022) Nicholas J. Fordham et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18
- (2022) Julia E. Rood et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care
- (2022) Prasad T. Oommen et al. CLINICAL IMMUNOLOGY
- First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
- (2022) Timothy Beukelman et al. Pediatric Rheumatology
- mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
- (2022) Zhengping Huang et al. Nature Communications
- Aberrant naive CD4+ T cell differentiation in systemic juvenile idiopathic arthritis is committed to B cell help
- (2022) Julia Kuehn et al. Arthritis & Rheumatology
- Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis
- (2021) Guillaume Morelle et al. Pediatric Rheumatology
- Refractory systemic juvenile idiopathic arthritis successfully treated with rapamycin
- (2021) Sara Concha et al. RHEUMATOLOGY
- A dysregulated interleukin-18–interferon-γ–CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis
- (2021) Tanja Hinze et al. RHEUMATOLOGY
- Biological classification of childhood arthritis: roadmap to a molecular nomenclature
- (2021) Peter A. Nigrovic et al. Nature Reviews Rheumatology
- Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data
- (2021) Rosemary G. Peterson et al. Pediatric Rheumatology
- Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
- (2021) Remco Erkens et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Interfering with Interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
- (2021) Emely L Verweyen et al. RHEUMATOLOGY
- Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study
- (2021) Christoph Kessel et al. Lancet Rheumatology
- Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
- (2021) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever
- (2021) Carolin Park et al. RHEUMATOLOGY
- Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
- (2020) Brigitte Bader-Meunier et al. ANNALS OF THE RHEUMATIC DISEASES
- Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
- (2020) Scott W. Canna et al. Pediatric Rheumatology
- Early treatment and il1rn snps affect response to anakinra in systemic juvenile idiopathic arthritis
- (2020) Manuela Pardeo et al. Arthritis & Rheumatology
- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes
- (2019) Erika Van Nieuwenhove et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis
- (2019) Faekah Gohar et al. ANNALS OF THE RHEUMATIC DISEASES
- Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics
- (2019) Priyankar Pal et al. INDIAN JOURNAL OF PEDIATRICS
- IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
- (2019) Shima Yasin et al. RHEUMATOLOGY
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Innately adaptive or truly autoimmune
- (2019) Christoph Kessel et al. Arthritis & Rheumatology
- Synergistic TLR/IFNα/β-Signaling Facilitates Escape of IL-18 Expression from Endotoxin Tolerance
- (2019) Emely Verweyen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- Impact of IL1RN variants on response to interleukin‐1 blocking therapy in systemic juvenile idiopathic arthritis
- (2019) Claas Hinze et al. Arthritis & Rheumatology
- Systemic juvenile idiopathic arthritis and macrophage activation syndrome
- (2018) Shima Yasin et al. CURRENT OPINION IN RHEUMATOLOGY
- Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany
- (2018) Claas H. Hinze et al. Pediatric Rheumatology
- Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis
- (2018) Nienke M. ter Haar et al. Arthritis & Rheumatology
- IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
- (2018) Victoria L. Arthur et al. Arthritis & Rheumatology
- T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells
- (2018) Aakanksha Jain et al. Nature Communications
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
- (2018) Alberto Martini et al. JOURNAL OF RHEUMATOLOGY
- Cutting Edge: Distinct Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β
- (2017) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013
- (2016) Jens Klotsche et al. Arthritis & Rheumatology
- HLA-DRB1*11and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
- (2015) Michael J. Ombrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
- (2014) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C
- (2014) Sarah Ringold et al. ARTHRITIS CARE & RESEARCH
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Thalidomide for systemic onset juvenile idiopathic arthritis
- (2013) K. Sathe et al. INDIAN PEDIATRICS
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis
- (2012) Dirk Holzinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
- (2012) Masaki Shimizu et al. CYTOKINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- Teratogenic effects of thalidomide: molecular mechanisms
- (2011) Takumi Ito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial
- (2010) Dirk Foell JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
- (2009) J Narvaez et al. ANNALS OF THE RHEUMATIC DISEASES
- The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis
- (2009) Michael Frosch et al. ARTHRITIS AND RHEUMATISM
- Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report
- (2009) M. Kasher-Meron et al. RHEUMATOLOGY
- S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin
- (2008) Helmut Wittkowski et al. ARTHRITIS AND RHEUMATISM
- Thalidomide: Mechanisms of Action
- (2008) Taraneh Paravar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now